A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

Suppr

超能文献

作者信息

Cryz S J, Fürer E, Sadoff J C, Germanier R

机构信息

Swiss Serum and Vaccine Institute, Berne.

出版信息

Antibiot Chemother (1971). 1987;39:249-55. doi: 10.1159/000414350.

DOI:10.1159/000414350

PMID:3118786

Abstract

摘要

相似文献

A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

Antibiot Chemother (1971). 1987;39:249-55. doi: 10.1159/000414350.

Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.

Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S644-9. doi: 10.1093/clinids/9.supplement_5.s644.

Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.

Infect Immun. 1987 Jul;55(7):1547-51. doi: 10.1128/iai.55.7.1547-1551.1987.

A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.

Antibiot Chemother (1971). 1987;39:215-21. doi: 10.1159/000414347.

Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans.

Antibiot Chemother (1971). 1989;42:177-83. doi: 10.1159/000417618.

Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.

Infect Immun. 1990 Feb;58(2):373-7. doi: 10.1128/iai.58.2.373-377.1990.

[Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].

Dokl Akad Nauk SSSR. 1988;298(5):1277-80.

Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.

APMIS. 1994 Jul;102(7):545-53.

A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.

Kitasato Arch Exp Med. 1988 Sep;61(2-3):81-93.

Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?

Hum Vaccin. 2007 Mar-Apr;3(2):39-40; author reply 41. doi: 10.4161/hv.3.2.3715. Epub 2007 Mar 8.

引用本文的文献

Efficacy of a serogroup O9 vaccine.

Infect Immun. 2023 Dec 12;91(12):e0024723. doi: 10.1128/iai.00247-23. Epub 2023 Nov 22.

Virulence Factors of and Antivirulence Strategies to Combat Its Drug Resistance.

Front Cell Infect Microbiol. 2022 Jul 6;12:926758. doi: 10.3389/fcimb.2022.926758. eCollection 2022.

Understanding -Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Cells. 2020 Dec 5;9(12):2617. doi: 10.3390/cells9122617.

Vaccines for Pseudomonas aeruginosa: a long and winding road.

Expert Rev Vaccines. 2014 Apr;13(4):507-19. doi: 10.1586/14760584.2014.890053. Epub 2014 Feb 27.

Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.

Infect Immun. 2001 Nov;69(11):6962-9. doi: 10.1128/IAI.69.11.6962-6969.2001.

Lactoferrin is a lipid A-binding protein.

Infect Immun. 1994 Jun;62(6):2628-32. doi: 10.1128/iai.62.6.2628-2632.1994.

Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Infect Immun. 1994 Aug;62(8):3564-7. doi: 10.1128/iai.62.8.3564-3567.1994.

Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.

Infect Immun. 1989 Dec;57(12):3851-5. doi: 10.1128/iai.57.12.3851-3855.1989.

Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.

Infect Immun. 1988 Jul;56(7):1829-30. doi: 10.1128/iai.56.7.1829-1830.1988.

Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.

Infect Immun. 1990 Feb;58(2):373-7. doi: 10.1128/iai.58.2.373-377.1990.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验